Accolade, Inc. (ACCD)
NASDAQ: ACCD · IEX Real-Time Price · USD
3.530
-0.010 (-0.28%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Accolade Market Cap
Accolade has a market cap or net worth of $282.43 million as of July 2, 2024. Its market cap has decreased by -69.70% in one year.
Market Cap
282.43M
Enterprise Value
292.38M
1-Year Change
-69.70%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $282.43M, a decrease of -79.77%. That is a compound annual growth rate of -32.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 283.20M | -69.07% |
| Dec 29, 2023 | 915.50M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -18.04% |
| Dec 31, 2020 | 2.14B | 53.60% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 291.40M |
| Alimera Sciences | 291.28M |
| Opthea | 290.97M |
| Zentalis Pharmaceuticals | 290.44M |
| Alto Neuroscience | 287.39M |
| LifeMD | 285.11M |
| Kamada | 285.07M |
| Tactile Systems Technology | 283.72M |